How Glaut uncovers deeper clinician motivations in pharma and healthcare research

Too Long; Don't Read

Pharma brand trackers depend on the insights they provide. Glaut’s AI-driven research platform enables researchers to go beyond basic scores and gain a deeper understanding of why clinicians make certain choices, all seamlessly integrated into a traditional quantitative survey.

• Discover the “why” behind traditional NPS ratings with personalized, conversational AI-led follow-ups
• Integrate an AI-Moderated module into your legacy surveys for open-ended questions
• Speed up analysis with automated transcription, open-ended coding, and agentic crosstabs.
• Scale globally and consistently across more than 50 languages.

In a quickly evolving pharmaceutical industry, Glaut transforms raw data into actionable insights, giving research teams a vital edge in understanding and connecting with healthcare professionals.

Why understanding clinician motivation matters?

Pharma researchers have long relied on quantitative trackers to measure KPIs like product quality, scientific leadership, innovation, and service support. These metrics are valuable, but they offer only a partial view of market dynamics and clinicians' opinions.

The real competitive advantage lies in understanding why clinicians prefer certain brands, and this is precisely where traditional research methods fall short.

• Doctors are time-poor and over-surveyed: whenfaced with open-ended survey questions, they tend to give brief, superficial answers or disengage entirely.
• Closed-ended questions with pre-defined answer options constrain responses to what researchers already expect to hear.
• While 1:1 interviews can generate genuine depth, they are expensive, slow to execute, and impossible to scale.

The result: research teams are left with data that measures sentiment, but rarely explains it.

Glaut AIMIs: the missing layer between scale and depth

Glaut's AI-moderated interviews (AIMIs) bridge this gap by embedding conversational, voice-first interviews directly within traditional digital surveys. This hybrid approach combines the statistical rigor and scale of quantitative research with the rich, exploratory nuance of qualitative depth, without disrupting existing workflows or extending respondent burden.

Unlike static open-ended text boxes, Glaut's AI moderator listens and adapts in real time: probing for clarity, asking for examples, and following up on what matters. Unlike generic follow-up prompts used in conventional CAWI tools, Glaut's probes are personalized to each respondent's answer, which is precisely what drives higher quality responses.

Clinicians can respond by voice or text, on any device, whenever it suits them. As a result engagement improves, while dropout and garbage answers decrease.

Key benefits for pharma research teams

• Richer responses: Clinicians speak in their own words freely, with fewer constraints. AI-moderated probing consistently produces significantly richer evidence than standard open-ended questions or generic follow-up methods.
• Higher engagement is achieved through conversational, voice-first interviews, which are perceived as less burdensome than traditional surveys. This leads to increased completion rates and a reduction in dropout rates and low-effort responses.
• Feedback that truly resonates: Pharma clients and brand teams can listen to the authentic voice of healthcare professionals, rather than just reading a summary. Audio files embed the clinician’s voice directly into stakeholder presentations.
• Scale seamlessly without compromise: conduct hundreds of interviews simultaneously in days—covering multiple markets and languages—at a fraction of the cost of traditional qualitative research.
• Quick analysis turnaround: automated transcription, open-ended coding, and sentiment tagging enable insights to be available within hours instead of weeks.

From data to motivation: transforming pharma brand intelligence

Rather than merely knowing which company leads on a given KPI, pharma stakeholders gain the nuanced reasoning behind prescription and loyalty decisions.

Operationally, the integration requires no additional interviewer training or complex protocols. Fieldwork runs within standard project timelines with no impact on respondent experience.

As the industry shifts toward more personalized, data-driven models, AI-moderated research is a practical necessity for teams that need to move faster without sacrificing depth.

Conclusion

Understanding why clinicians prefer one pharma company over another is a strategic imperative. Glaut AIMIs empower pharma researchers to capture meaningful motivation within their quantitative trackers, transforming raw KPI data into actionable intelligence that drives smarter decisions.

To explore how Glaut can elevate your next pharma brand tracking or competitive intelligence project, get in touch or book a demo at glaut.com.